Modulatory effect of Vibrio cholerae toxin co-regulated pilus on mucins, toll-like receptors and NOD genes expression in co-culture model of Caco-2 and peripheral blood mononuclear cells (PBMC).

Vibrio cholerae, the causative agent of cholera, tend to colonize the small intestine as a Gram-negative pathogen. The intestinal mucus layer forms mucin physical barrier, consisted of high molecular weight proteins. Regarding the role of toxin-coregulated pilus (TCP) as one of the most important colonization factors of V. cholerae, this experimental study was designed to determine the role of TcpA in induction of mucin production and its regulatory effect on innate immunity molecules including toll like receptors (TLRs) and Nucleotide-binding oligomerization domain-containing proteins (NODs) using Caco2- PBMC co-cultures as an interactive model. The rTcpA protein of V. cholerae was expressed in BL21 Escherichia coli, purified using Ni-column chromatography and confirmed by western blotting. Nontoxic doses of rTcpA was determined on Caco-2 cell lines and different concentrations of rTcpA (1, 5, 10 and 50 μg/mL) showed a statistically significant effect on the expression of muc genes (MUC3 and MUC4) in a dose-dependent manner. This finding is supposed to facilitate physical adhesion and colonization of V. cholerae in intestinal lumen. The rTcpA moderately stimulated the expression of tlr4 and overexpressed tlr1, both of which are supposed to induce a mucosal protective response against bacterial infection. NOD2 was significantly increased which suggests that it may contribute in pro-inflammatory responses observed in cholera disease. No change in NOD1 expression was seen which might be attributed to the non-invasive nature of V. cholerae as an intestinal pathogen. In conclusion, the rTcpA protein of V. cholerae showed a statistically significant modulatory effect on the human gut epithelium gene expression which would help promising protection in prophylaxis applications.

[1]  R. Wubbolts,et al.  MUC1 is a receptor for the Salmonella SiiE adhesin that enables apical invasion into enterocytes , 2019, PLoS pathogens.

[2]  Faster Isolation of PBMC Using Ficoll-Paque® Plus in the Eppendorf Multipurpose Benchtop Centrifuges 5920 R and 5910 Ri , 2019 .

[3]  M. Raza,et al.  Interferon-gamma (IFN-γ): Exploring its implications in infectious diseases , 2018, Biomolecular concepts.

[4]  J. V. van Putten,et al.  Transmembrane Mucins: Signaling Receptors at the Intersection of Inflammation and Cancer , 2017, Journal of Innate Immunity.

[5]  L. Abdul-Lateef,et al.  Molecular detection of cholera toxin genes in Vibrio cholerae infection in human , 2017 .

[6]  Payam Behzadi,et al.  The role of toll-like receptors (TLRs) in urinary tract infections (UTIs) , 2016, Central European journal of urology.

[7]  L. Álvarez-Vallina,et al.  Role of nucleotide‐binding oligomerization domain 1 (NOD1) in pericyte‐mediated vascular inflammation , 2016, Journal of cellular and molecular medicine.

[8]  G. Gambassi,et al.  How the Intricate Interaction among Toll-Like Receptors, Microbiota, and Intestinal Immunity Can Influence Gastrointestinal Pathology , 2015, Journal of immunology research.

[9]  Ronald K. Taylor,et al.  Intestinal Colonization Dynamics of Vibrio cholerae , 2015, PLoS pathogens.

[10]  K. Chaudhuri,et al.  Toll-like Receptor (TLR) and Nucleotide-Binding Oligomerization Domain (NOD) Signaling during Vibrio Cholerae Infection , 2015 .

[11]  S. Cornick,et al.  Roles and regulation of the mucus barrier in the gut , 2015, Tissue barriers.

[12]  S. Esmaeili,et al.  THE EFFECT OF SOME COSOLVENTS AND SURFACTANTS ON VIABILITY OF CANCEROUS CELL LINES , 2014 .

[13]  R. Flavell,et al.  Interactions between Nod-Like Receptors and Intestinal Bacteria , 2013, Front. Immunol..

[14]  Jun Ye,et al.  Enhanced Membrane-tethered Mucin 3 (MUC3) Expression by a Tetrameric Branched Peptide with a Conserved TFLK Motif Inhibits Bacteria Adherence* , 2013, The Journal of Biological Chemistry.

[15]  M. McGuckin,et al.  MUC1 and MUC13 differentially regulate epithelial inflammation in response to inflammatory and infectious stimuli , 2012, Mucosal Immunology.

[16]  D. Zamboni,et al.  NOD1 and NOD2 Signaling in Infection and Inflammation , 2012, Front. Immun..

[17]  Karla J. F. Satchell,et al.  Neutrophils Are Essential for Containment of Vibrio cholerae to the Intestine during the Proinflammatory Phase of Infection , 2012, Infection and Immunity.

[18]  Ronald K. Taylor,et al.  Protection and Attachment of Vibrio cholerae Mediated by the Toxin-Coregulated Pilus in the Infant Mouse Model , 2011, Journal of bacteriology.

[19]  G. Macfarlane,et al.  Induction of cytokine formation by human intestinal bacteria in gut epithelial cell lines , 2011, Journal of applied microbiology.

[20]  H. Fang,et al.  Inhibitory effects of Lactobacillus casei subsp. rhamnosus on Salmonella lipopolysaccharide-induced inflammation and epithelial barrier dysfunction in a co-culture model using Caco-2/peripheral blood mononuclear cells. , 2010, Journal of medical microbiology.

[21]  V. Lievin-Le Moal,et al.  Two Atypical Enteropathogenic Escherichia coli Strains Induce the Production of Secreted and Membrane-Bound Mucins To Benefit Their Own Growth at the Apical Surface of Human Mucin-Secreting Intestinal HT29-MTX Cells , 2010, Infection and Immunity.

[22]  J. Mason,et al.  Differential expression and regulation of nuclear oligomerization domain proteins NOD1 and NOD2 in human endometrium: a potential role in innate immune protection and menstruation. , 2009, Molecular human reproduction.

[23]  M. McGuckin,et al.  Mucin Dynamics in Intestinal Bacterial Infection , 2008, PloS one.

[24]  V. Srivastava,et al.  Role of Intestinal Mucins in Innate Host Defense Mechanisms against Pathogens , 2008, Journal of Innate Immunity.

[25]  H. Koley,et al.  Intestinal Adherence of Vibrio cholerae Involves a Coordinated Interaction between Colonization Factor GbpA and Mucin , 2008, Infection and Immunity.

[26]  D. Spandidos,et al.  Genomic instability, mutations and expression analysis of the tumour suppressor genes p14(ARF), p15(INK4b), p16(INK4a) and p53 in actinic keratosis. , 2008, Cancer letters.

[27]  S. Batra,et al.  Structure, evolution, and biology of the MUC4 mucin , 2008, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[28]  V. Korolik,et al.  MUC1 cell surface mucin is a critical element of the mucosal barrier to infection. , 2007, The Journal of clinical investigation.

[29]  S. Khader,et al.  IL-12p40: an inherently agonistic cytokine. , 2007, Trends in immunology.

[30]  S. Calderwood,et al.  Transcutaneous Immunization with Toxin-Coregulated Pilin A Induces Protective Immunity against Vibrio cholerae O1 El Tor Challenge in Mice , 2006, Infection and Immunity.

[31]  B. Xia,et al.  IL-4 induced MUC4 enhancement in respiratory epithelial cells in vitro is mediated through JAK-3 selective signaling , 2006, Respiratory research.

[32]  Li Zhou,et al.  Increased expression of Toll like receptor 4 on peripheral‐blood mononuclear cells in patients with coronary arteriosclerosis disease , 2006, Clinical and experimental immunology.

[33]  G. Macfarlane,et al.  Toll‐like receptors‐2, ‐3 and ‐4 expression patterns on human colon and their regulation by mucosal‐associated bacteria , 2005, Immunology.

[34]  S. Akira,et al.  Toll-like receptors in innate immunity. , 2004, International immunology.

[35]  T. van der Poll,et al.  Role ofToll-Like Receptor 4 in Gram-Positive and Gram-Negative Pneumonia inMice , 2004, Infection and Immunity.

[36]  D. Maskell,et al.  Stimulation of Toll-Like Receptor 4 by Lipopolysaccharide During Cellular Invasion by Live Salmonella typhimurium Is a Critical But Not Exclusive Event Leading to Macrophage Responses1 , 2003, The Journal of Immunology.

[37]  W. Gillanders,et al.  Quantitative real‐time RT‐PCR detection of breast cancer micrometastasis using a multigene marker panel , 2001, International journal of cancer.

[38]  A. Pfeifer,et al.  Non-pathogenic bacteria elicit a differential cytokine response by intestinal epithelial cell/leucocyte co-cultures , 2000, Gut.

[39]  S. Müller,et al.  MUC1: the polymorphic appearance of a human mucin. , 2000, Glycobiology.

[40]  M. Engle,et al.  Caco‐2 cells express a combination of colonocyte and enterocyte phenotypes , 1998, Journal of cellular physiology.

[41]  J. Kraehenbuhl,et al.  Epithelial M Cells: Gateways for Mucosal Infection and Immunization , 1996, Cell.